OTCMKTS:NXTTF – Facts About CBD

Lifeist Wellness Inc (OTCMKTS: NXTTF) Launches Mikra Cellular Sciences Inc

Lifeist Wellness Inc (OTCMKTS: NXTTF) has announced the launch of Mikra Cellular Sciences Inc, a consumer wellness and bioscience company. The company will partner with Silver...

BUSINESS3 years ago

Lifeist Wellness Inc.’s (OTCMKTS: NXTTF) Subsidiary CannaMart Inc. Produces First 2.0 Consumer-focused “Roilty” Brand

Lifeist Wellness Inc. (OTCMKTS: NXTTF) has announced that its wholly-owned subsidiary and portfolio business CannaMart Labs Inc. has produced its maiden products under 2.0 consumer-focused brand...

BUSINESS3 years ago

Lifeist Wellness Inc (OTCMKTS: NXTTF) Reports its gross Revenue Increased 12% and Acquired $7.1 Million led by Cannabis Growth

Lifeist Wellness Inc (OTCMKTS: NXTTF) advances in science and technology to find a path for your wellness reported their financial results that ended on August 31,...

BUSINESS5 years ago

CannMart Inc., A Subsidiary Of Namaste Technologies Inc (OTCMKTS:NXTTF), Serves B2B Customers And Online Patients: Enters A Pact With Adastra Labs To Supply Cannabis Concentrates And Extracts

Non-essential businesses are asked to shut down by the Ontario Government to prevent the spread of coronavirus. However, the Ontario Government has exempted cannabis retail and...

BUSINESS5 years ago

Namaste Technologies Inc (OTCMKTS:NXTTF) Releases Details Of Its 019 Annual Shareholder Meeting

Namaste Technologies Inc (OTCMKTS:NXTTF) recently disclosed the results of this year’s Annual Shareholder Meeting which took place in Toronto, Ontario on June 25. The announcement revealed...

CBD CONDITIONS & TREATMENTS6 years ago

Namaste Technologies Provides Bi-Weekly Default Status Report And Corporate Update

Namaste Technologies Inc. (OTCMKTS:NXTTF) has provided its fourth bi-weekly default status in line with the National Policy 12-203-Cease Trade Order. Bi-weekly status report On April 2,...

Facts About CBD

All posts tagged "OTCMKTS:NXTTF"

Lifeist Wellness Inc (OTCMKTS: NXTTF) Launches Mikra Cellular Sciences Inc

Lifeist Wellness Inc.’s (OTCMKTS: NXTTF) Subsidiary CannaMart Inc. Produces First 2.0 Consumer-focused “Roilty” Brand

Lifeist Wellness Inc (OTCMKTS: NXTTF) Reports its gross Revenue Increased 12% and Acquired $7.1 Million led by Cannabis Growth

CannMart Inc., A Subsidiary Of Namaste Technologies Inc (OTCMKTS:NXTTF), Serves B2B Customers And Online Patients: Enters A Pact With Adastra Labs To Supply Cannabis Concentrates And Extracts

Namaste Technologies Inc (OTCMKTS:NXTTF) Releases Details Of Its 019 Annual Shareholder Meeting

Namaste Technologies Provides Bi-Weekly Default Status Report And Corporate Update

Trulieve Cannabis Corp (OTCMKTS: TCNNF) Announces a Listening and Education Tour

Medical Marijuana Inc’s (OTCMKTS: MJNA) Subsidiary, HempMeds Brasil, Will Sponsor an Obesity Medicine Symposium

Fire & Flower Holdings Corp’s (OTCMKTS: FFLWF) Subsidiary, Pineapple Express Delivery Inc, Will Offer Delivery in Metro Vancouver

Medipharm Labs Corp (OTCMKTS: MEDIF) Completes a Drug Master File (DMF) For API

Hexo Corp (NASDAQ: HEXO) and Kaos Capital Change Hexo’s Board of Directors

Title

Trulieve Cannabis Corp (OTCMKTS: TCNNF) Announces a Listening and Education Tour

Medical Marijuana Inc’s (OTCMKTS: MJNA) Subsidiary, HempMeds Brasil, Will Sponsor an Obesity Medicine Symposium

Fire & Flower Holdings Corp’s (OTCMKTS: FFLWF) Subsidiary, Pineapple Express Delivery Inc, Will Offer Delivery in Metro Vancouver

Medipharm Labs Corp (OTCMKTS: MEDIF) Completes a Drug Master File (DMF) For API

Hexo Corp (NASDAQ: HEXO) and Kaos Capital Change Hexo’s Board of Directors

Net Savings Link Inc (OTCMKTS: NSAV) Announces Its Partnership With Metaverse LLC To Purchase 50% of HIVE

Puration Inc’s (OTCMKTS: PURA) CEO Releases Letter to Shareholders Regarding the Its Latest Venture

Jushi Holdings Inc (OTCMKTS: JUSHF) Announces a Variety of Products That It Intends To Launch Before and During the 2nd Quarter Announcements

Pharmacyte Biotech Inc (NASDAQ: PMCB) Gets Ready to Resubmit Investigational New Drug (IND) to the FDA